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Abstract
Background: For patients' safety reasons, current American Heart Association and European
Resuscitation Council guidelines recommend intraosseous (IO) vascular access as an alternative in
cases of emergency, if prompt venous catheterization is impossible. The purpose of this study was
to compare the IO access as a bridging procedure versus central venous catheterization (CVC) for
in-hospital adult emergency patients under resuscitation with impossible peripheral intravenous
(IV) access. We hypothesised, that CVC is faster and more efficacious compared to IO access.
Methods: A prospective observational study comparing success rates and procedure times of IO
access (EZ-IO, Vidacare Corporation) versus CVC in adult (≥18 years of age) patients under
trauma and medical resuscitation admitted to our emergency department with impossible
peripheral IV catheterization was conducted. Procedure time was defined from preparation and
insertion of vascular access type until first drug or infusion solution administration. Success rate on
first attempt and procedure time for each access route was evaluated and statistically tested.
Results: Ten consecutive adult patients under resuscitation, each receiving IO access and CVC,
were analyzed. IO access was performed with 10 tibial or humeral insertions, CVC in 10 internal
jugular or subclavian veins. The success rate on first attempt was 90% for IO insertion versus 60%
for CVC. Mean procedure time was significantly lower for IO cannulation (2.3 min ± 0.8) compared
to CVC (9.9 min ± 3.7) (p < 0.001). As for complications, failure of IO access was observed in one
patient, while two or more attempts of CVC were necessary in four patients. No other relevant
complications, like infection, bleeding or pneumothorax were observed.
Conclusion: Preliminary data demonstrate that IO access is a reliable bridging method to gain
vascular access for in-hospital adult emergency patients under trauma or medical resuscitation with
impossible peripheral IV access. Furthermore, IO cannulation requires significantly less time to
enable administration of drugs or infusion solutions compared to CVC. Because CVC was slower
and less efficacious, IO access may improve the safety of adult patients under resuscitation in the
emergency department.
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Success rate and time need for vascular access is crucial in
the emergency patient under resuscitation. However,
peripheral intravenous (IV) access might be difficult espe-
cially in the dehydrated or hemodynamic unstable,
injured or critically ill patient with collapsed peripheral
veins. Also chemotherapy and long-term IV drug addic-
tion can lead to inaccessible peripheral veins. Failure rates
of IV access in emergency situations are described between
10-40% [1-3]. Reattempts to gain vascular access lead to
valuable time loss with potential subsequent influence of
patients' safety. The average time necessary for peripheral
IV catheterization is reported to add up to 2.5-13 min, and
sometimes even up to 30 min in patients with difficult to
access peripheral veins [1-5]. This can lead to a delay of
necessary treatment and longer on-scene times [6]. Longer
on-scene times might be followed by additional delay in
the emergency department, when reattempting vascular
access. Also isolated prolongation of on-scene time delays
definitive treatment. Time lag of necessary diagnostic and
treatment procedures consecutively compromises the
emergency patient [7,8]. Therefore, current evidence
based practice management guidelines for the prehospital
fluid resuscitation in injured patients of the Eastern Asso-
ciation for the Surgery of Trauma (EAST) recommends not
to perform vascular access on scene, if it delays patient
transport to definitive care [9].
Alternative ways of drug and fluid administration are sub-
lingual, endotracheal, subcutaneous and intramuscular
application. However, these options do not really reflect a
reasonable possibility, due to its uncertain and uncon-
trolled administration of substance dosages with incalcu-
lable pharmacodynamic and pharmacokinetic effects.
Furthermore, only small amounts of certain applicable
drugs can be given and volume resuscitation or transfu-
sion of blood products are impossible at all [10,11].
If vascular access is necessary in the acute setting of unsta-
ble patients admitted to the emergency department, and
peripheral IV cannulation is impossible, central venous
catheterization (CVC) is a common alternative procedure
[10,11]. Besides providing vascular access for fluid resus-
citation, CVC also allows hemodynamic monitoring [12-
15]. However CVC is relatively time-consuming and asso-
ciated with relevant risks for the patient, especially in the
emergency setting. Most frequent complications include
venous thrombosis, catheter related infections, arterial
puncture and pneumothorax [12,14-17].
Consequently, a different vascular access technique may
be reasonable to increase patients' safety, at least as a
bridging procedure during ongoing resuscitation efforts
until the patient is in a more stable condition. In this
respect, intraosseous (IO) vascular access is an option,
already established in paediatric patients for decades
[18,19]. Its importance in adults is less propagated, espe-
cially for in-hospital use. In general, IO cannulation of the
non-collapsible and highly vasculated intramedullary
venousplexus of the concellous bone marrow can provide
a rapid, safe and easy vascular access to administer drugs,
volume and blood products to the emergency patient. All
metaphyseal segments of long bones are filled with highly
perfused bone marrow, which are able to transport
applied drugs and fluids to the central vascular system
rapidly. Transport times are reported to be 1-2 min, even
during cardiopulmonary resuscitation with chest com-
pressions [10,11]. Therefore the aim of the present study
was to compare the IO access versus CVC regarding suc-
cess rate of the procedure on first attempt and procedure
time needed in adult patients under trauma or medical
resuscitation admitted to our emergency department with
impossible peripheral IV access. We hypothesised, that
CVC is faster and more efficacious compared to IO access.
Methods
Study design
This prospective observational study was conducted in the
emergency department of an urban level I trauma centre.
Consecutive adult injured or critically ill patients (≥18
years of age) brought to our resuscitation bay were
included, without or insufficient peripheral IV catheteri-
zation and necessary immediate vascular access. A senior
attending physician, consultant in surgery and emergency
medicine, directed resuscitative efforts following the
Advanced Trauma Life Support protocol for injured and
the Advanced Cardiac Life Support protocol for ill
patients. The local ethics committee approved this study.
Written informed consent was obtained from each
patient, when returning to full consciousness or from the
next of kin or a legal representative. With the present anal-
ysis, we evaluated the retrieved data of the first 10 patients
included in our study.
Patient demographics
The patient's baseline characteristics such as age, gender,
injury or cause of vital organ disorder were retrieved sub-
sequently if not available on admission. All treatment
data and measured parameters assessed in the resuscita-
tion room were prospectively collected and recorded in a
structured form for each patient.
Treatment protocol
During the initial resuscitation in accordance with the
present standards of care, peripheral IV access was
attempted three times for a maximum of 2 min. If unsuc-
cessful, IO access and CVC was performed simultaneously
in a standardized course of action by two independent
participants. A third independent observer with two stop-
watches took the time of each procedure. The measured
time of each procedure was defined as the duration of
picking up the prepared set of IO or CVC access devicePage 2 of 8
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insertion site including desinfection and draping, inser-
tion procedure of IO access or CVC itself, assembling of
the access set and first successful administration of drugs
or infusion solutions through the newly established vas-
cular access. Success rate of the procedure on first attempt
was defined as successful administration of drugs or infu-
sion solutions via the performed vascular IO or CVC
access on first effort. Failure was defined as more than one
(the first) effort to enable drug or infusion solution
administration, e.g. due to impossible insertion or
advancing the guidewire in CVC. On the other hand, more
than one effort to puncture a central vein was not distinct
as unsuccessful procedure on first attempt.
Participants
Each two independent participants were trained consult-
ants and well experienced in resuscitation. Anaesthesiolo-
gists performed CVC while surgeons provided the IO
access. Each surgical participant received a 60 min lecture
on the use and technique of the IO device, including
standardized educational videos, a demonstration and an
independent, self-performed insertion on the IO model.
Central venous catheterization
CVC was performed in a standardised procedure using
landmark orientated standard Seldinger technique
[16,20]. For hemodynamic monitoring option, internal
jugular or subclavian vein was preferred to femoral access.
According to our protocol, insertion site was primarily
subclavian vein for CVC, but a different insertion site was
chosen appropriate to injury pattern. For CVC a standard
triple- or quad-lumen 7-French catheter (Arrow Interna-
tional Inc., 155 South Limerick Road, Limerick, PA
19468-1699, USA) was used, depending on patients'
need. A chest radiograph was obtained in each patient fol-
lowing CVC to confirm placement and assess for compli-
cations.
Intraosseous vascular access
IO access was achieved in a standardised procedure apply-
ing landmark orientated standard technique [21-27].
According to our protocol, insertion site was primarily
proximal humerus for IO cannulation, but a different
insertion site was chosen appropriate to injury pattern. IO
access was performed with a battery driven device, the EZ-
IO system from Vidacare Corporation (Vidacare Corpora-
tion, 722 Isom Road, San Antonio, TX 78216, USA). It
contained a lithium battery-powered drill driven handle
and a 15-gauge (1.8 mm), 25 mm in length, stainless EZ-
IO AD cannula for adults with extension tubing. The reus-
able 14 × 9 × 5 cm sized driver weighs 455 grams and
should provide 1000 insertions or 10 years of shelf life
according to the manufacturer (Fig. 1).
There are three different cannula sizes available depend-
ing on patients' age: EZ-IO PD 15 mm in length for paedi-
atric patients from 3-39 kg weight, EZ-IO AD 25 mm in
length for adult patients >39 kg weight and EZ-IO LD 45
mm in length for obese patients or patients with excessive
tissue over the insertion site (Fig. 2).
Once the IO cannula is attached to the driver, the needle
is inserted power-driven under gentle manual pressure.
After insertion, the driver and stylet of the cannula has to
be removed leaving the IO catheter in place. The inserted
catheter has to be attached to the extension tubing and
followed by a syringe saline flush before drug and infu-
sion solution administration. FDA approved the EZ-IO for
humeral head, proximal and distal tibial (medial malleo-
lus) access in adults, as well as for proximal tibial access in
paediatric patients. Contraindications of IO access are rare
and relative in cases of life threatening injuries or illness.
However, the IO cannula should not be inserted into a
fractured bone to avoid extravasation, in the absence of
adequate anatomical landmarks due to excessive tissue, if
infection at the area of insertion is obvious, and following
previous IO access or significant orthopaedic procedure
like limb or joint prosthesis at the insertion site. Each IO
cannula was removed within 24 hours of insertion accord-
ing to manufacturers recommendations.
Follow up and complications
Patient follow up was performed until hospital discharge.
If patients were discharged from the hospital within 14
days of admission, a standardized telephone interview
with the relevant patients 2 weeks after hospital admis-
sion was conducted. Possible complications were deter-
mined a priori and a list was defined based on the well-
reported complications in literature [16,20-27]. Based on
this list, complications occurring under or following vas-
cular access procedures were recorded for each access
attempt in all patients with a standardized protocol. This
protocol defined the assessment of complications for each
patient in the exact same way regarding vascular access
type, time and kind of complication. Possible complica-
tions included failure of vascular access, malposition, dis-
lodgment, bleeding, compartment syndrome, arterial
puncture, haematothorax, pneumothorax, venous throm-
bosis and vascular access related infection. For instance to
assess for complications following CVC, each patient
obtained a chest radiograph. To determine vascular access
related infection, insertion sites were inspected and docu-
mented three times daily. Additionally, every IO cannula
and central venous catheter tip was microbiologically
examined after its removal.
Statistical analysis
For statistical testing SPSS version 13.0 software (SPSS,
Chigaco IL, USA) was employed. According to the distri-Page 3 of 8
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Mann-Whitney Rank Sum test was applied to analyze the
differences in procedure times between the two vascular
access techniques at a significance level of p = 0.05.
Results
Four women and six men, ranging in age from 18 to 70
(on average 39.7 ± 18.2) years were included. The IO
insertion site was proximal tibial in four patients, and
humeral in six patients. CVC was achieved in three inter-
nal jugular veins, and in seven subclavian veins.
The success rate on first attempt was 90% for IO access
versus 60% for CVC. One IO cannulation failed due to
operator mishandling by not selecting the correct inser-
tion site at the proximal humerus. The IO catheter did not
reach the bone marrow because of the overlying soft tissue
at the incorrect insertion site. Four CVC procedures failed
at first attempt, requiring at least one more attempt. In all
unsuccessful CVC attempts the guidewire was unable to
be inserted or advanced into the vessel.
The mean time required for the vascular access procedure
was significantly shorter (p < 0.001) for IO cannulation
(2.3 min ± 0.8; time range 1-3 min) compared to CVC
(9.9 min ± 3.7; time range 5-17 min) (Fig. 3).
Beside the above mentioned unsuccessful access proce-
dures on first attempt following IO cannulation or CVC,
no further complications were detected. Especially no
malposition, dislodgment, bleeding, compartment syn-
drome, arterial puncture, haematothorax, pneumothorax,
venous thrombosis and vascular access related infection
was observed.
Discussion
Present guidelines of the Eastern Association for the Sur-
gery of Trauma (EAST) and the National Association of
EMS Physicians (NAEMSP) advocate IO access in the pre-
hospital setting, if peripheral venous catheterization is
impossible [9,28]. Because lacking peripheral IV access is
also an issue in adults under in-hospital resuscitation, we
were interested whether IO approach could be an alterna-
tive in the emergency department. To our knowledge, no
other study has prospectively compared IO access versus
standard alternative vascular access procedures in a real
scenario for in-hospital patient care yet. Therefore, we
investigated the in-hospital IO approach versus CVC in
adult patients under resuscitation lacking peripheral IV
access. IO cannulation was performed as a bridging proce-
dure and was compared to CVC regarding success rate on
first attempt and procedure duration. Our results show
that IO vascular access was significantly more successful
and required significantly less time when compared to
CVC.
Today, there are different techniques of IO access availa-
ble, also for the adult. Several out-of-hospital trials docu-
mented, that IO approach is consistent, rapid, and safe for
drug delivery and fluid resuscitation in adults. Different
investigators reported successful vascular access within 1-
2 min in 72-100% of patients [21-24,26,27]. In two pro-
spective out-of-hospital trials including more than 500
adults, IO cannulation was even successful within 20 sec
in 95-97% of patients [21,26].
Only a small number of trials evaluated the isolated utili-
zation of in-hospital IO access in severely injured or criti-
cally ill adults. Ong et al. published their experience of 24
tibial and 11 humeral successful IO insertions in alto-
gether 24 adults. Success rate at first attempt was 97% (34/
35); a second attempt was necessary for one tibial access.
All insertions were achieved within 20 sec, relevant com-
plications did not occur [25]. Valdes already reported in
1977 about IO access in 15 critically ill adults (18-86 years
of age) with a success rate of 87% (13/15). In these
patients, an average of 4 litres were administrated for an
average of 5.4 days. Complications like infection or
emboli did not occur. Application times for IO access
Battery driven intraosseous vascular access device (EZ-IO®, Vidacare®)F gu e 1
Battery driven intraosseous vascular access device 
(EZ-IO®, Vidacare®).Page 4 of 8
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application of IO access in 22 adults (36-84 years of age)
suffering cardiac arrest. Application time was <1 min and
complications were not reported [30]. Cooper et al. pub-
lished their experience of 22 successful inserted IO nee-
dles in adults in the military combat environment.
Success rate was 97%, relevant complications did not
occur, especially no infection [31]. In line with these find-
ings, our results show also a high success rate of 90% and
a low mean procedure time of 2.3 min. However, our
recorded procedure time included not only the IO inser-
tion itself, but also the preparation of the insertion site,
the device and its assembling until the administration of
drugs or fluids.
The majority of insertion sites for IO access in the adult
include the sternum, medial clavicle, proximal humerus,
distal radius, proximal tibia, distal tibia and distal fibula
[21-27,29-31].
Following an instruction course of a maximum of 2 hours,
the safe and rapid use of diverse IO access devices are
demonstrated by different studies. Regarding learnability
and handling, data reveal success rates of 93-100% in IO
access performance within 2 min [32-37].
Most drugs can be administered IO in equivalent dosage
and with the same time effect compared to IV. Pharmaco-
dynamic and pharmacokinetic effects of IO applied drugs
and infusions are well described in the literature [38-41].
Currently no resuscitation drugs are contraindicated for
IO administration. In our study, we mainly administered
common resuscitation drugs, beside crystalloid and col-
loid solutions, red packed cells, and fresh frozen plasma.
Over all, flow rates of IO vascular access are lower than
large bore peripheral IV catheters, and depend on patients'
age, site of insertion and cannula size. Most IO cannulas
for adults are 15-gauge needles, and enable flow rates
comparable to a 20-gauge peripheral IV catheter. IO Flow
rates on gravidity account between 10-34 ml/min and can
be increased up to 80-165 ml/min using a pressure bag
[25,42-45]. Therefore IO rapid volume resuscitation is
limited, however two or more IO cannulations in the
same patient may facilitate fluid therapy [25].
Limitations and risks of IO access have to be considered.
According to manufacturers' recommendations, fractured
bones should not be cannulated due to the risk of extrava-
sation at the fracture site. Furthermore, to minimize infec-
tion risks, areas of limb or joint prosthesis should not be
selected as insertion site. IO needles should be removed
within 24 hours after insertion and no further IO cannu-
lation should be performed at the same site within 24
hours. Obvious infection at the insertion site contraindi-
cates IO access. However, in life threatening conditions,
these contraindications are relative.
Regarding complications following IO access, the rate of
adverse events is described low in literature. Immediate
complications include device failure, extravasation, fat
embolism, fracture of the canullated bone and compart-
ment syndrome of the concerning limb. The only prospec-
tive studies of IO access, including 553 adults, described
none of these complications [21,25,26]. Late complica-
tions following IO access include osteomyelitis and bone
marrow necrosis. Subsequent 4,270 IO cannulations of
the sternum or tibia in children, infection rate was 0.6%
[46]. Other authors found fewer or no infections at all.
The risk for infection seems to correlate with exposure
time of IO access exceeding several days, pre-existing
bacteraemia, insufficient asepsis on insertion and usage as
well as administration of hypertonic fluids [21,26,47].
Negative long-term effects for the cannulated bone, epi-
physial plates or bone marrow in humans following IO
infusion have not been demonstrated so far [48]. In our
study population no IO related complication was detecta-
ble. Especially device-associated infection could be
excluded by routine inspection of the insertion site three
times daily and microbiological examination of each
removed IO cannula.
Alternative vascular access techniques in the adult patient
under resuscitation with impossible peripheral IV cathe-
terization include CVC, ultrasound-guided catheteriza-
tion of peripheral veins, and saphenous vein cutdown.
CVC provides vascular access for fluid resuscitation,
vasoactive medication and antibiotics. Furthermore, it
allows hemodynamic monitoring and cardiac pacing [12-
15]. However, CVC is relatively time-consuming and asso-
ciated with complications, especially in the emergency
setting. Complication rates for CVC are reported around
Different EZ-IO® cannula sets (Vidacare®) depending on pati nts age and excessive tis ue over the ins rtion site (pink: EZ-IO PD for pedi tric pa ients; blue: EZ-IO AD for adult ; y llow: EZ-IO LD for o es patients or pati nts w h excessive tissu  over the ins rtion site)Figu  2
Different EZ-IO® cannula sets (Vidacare®) depending 
on patients age and excessive tissue over the inser-
tion site (pink: EZ-IO PD for pediatric patients; blue: EZ-IO 
AD for adult patients; yellow: EZ-IO LD for obese patients 
or patients with excessive tissue over the insertion site).Page 5 of 8
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hematoma, pneumothorax, venous thrombosis and cath-
eter related infections [12,14-17]. The average risk of CVC
related infections in the critical ill patient accounts for 5.3
per 1,000 catheter days and leads to 80,000 CVC-associ-
ated bloodstream infections and consecutively up to
28,000 deaths in U.S. intensive care units each year. Mor-
tality for hospitalized patients with CVC related infection
accounts for 12-25%. The attributable cost per infection is
estimated USD 34,508-56,000. Furthermore, CVC is rela-
tively contraindicated for fibrinolytic therapy [10,49,50].
In our study none CVC related complications were detect-
able.
Ultrasound-guided peripheral IV access enables success
rates of 92%. However, the necessary time adds up to 2.5-
4 min for catheter cannulation itself, and up to 13 min for
the whole procedure. Furthermore, this approach requires
the ultrasound device and an experienced operator
[4,5,51].
Saphenous vein cutdown is slow, less successful and asso-
ciated with risks. The reported time need for this invasive
vascular access procedure was 2-7.6 min with a success
rate of 69-94%, when performed by experienced person-
nel. Trauma to the lower extremities might preclude
saphenous vein cutdown. Time effect of administered
drugs and fluids to the saphenous vein may be delayed
due to long distance between vein cutdown and the heart,
especially in shock conditions with impaired circulation
[52-55].
Several potential limitations of this study have to be
addressed. First, the sample size of this study is small due
to its preliminary analysis of the first 10 consecutive
patients. However, there was a statistically significant dif-
ference in procedure times of enabling vascular access,
resulting in a time benefit for the IO approach (p < 0.001).
Second, a potential bias of the investigators favouring
towards the IO access was limited by performing both vas-
cular access methods simultaneously by two independent
operators. Third, differences in access success rates on first
attempt and procedure times due to unequal experience
in the applied techniques were limited by determining
each participant to be an experienced consultant with
long lasting expertise in resuscitation in the emergency
department following standardized protocols.
As a consequence of the present study, we continued the
IO vascular access protocol as a bridging procedure in
adult patients under resuscitation in the emergency
department with impossible peripheral IV access. To eval-
uate the handling of different IO access devices, we
included different IO systems in our modified protocol of
the ongoing trial.
Conclusion
IO vascular access is a safe, reliable and rapid option in the
acute setting of adult patients under resuscitation with
inaccessible peripheral veins in the emergency depart-
ment. Compared to CVC, IO cannulation is more success-
ful on first attempt and requires significantly less time.
However, IO access is not a surrogate for CVC and cannot
replace it. Complications following IO access are rare,
providing correct indication, training skills and adequate
handling. Therefore, a change in practice from CVC to
immediate IO access for the initial emergency resuscita-
tion should be strongly considered as a reasonable bridg-
ing technique to increase patients' safety in the emergency
department, if peripheral IV access was attempted unsuc-
cessful three times for a maximum duration of 2 min.
These findings are in accordance with current guidelines
of the American Heart Association and the European
Resuscitation Council [10,11]. Based on our findings, fur-
ther prospective large-scale randomized trials are neces-
sary to provide the treating physician with clear, evidence-
based guidelines in the future.
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